Alastair leads a team committed to ensuring that the best innovation within the broad field of ‘artificial intelligence’ is translated safely, efficiently, equitably and inclusively to patients. This includes improving the design and reporting of clinical trials in this area (international standards CONSORT-AI and SPIRIT-AI), highlighting issues of representativeness including the risk of health data poverty; developing tools to support safe deployment (including validation datasets); and working with regulators and other stake-holder groups to support the best of these innovations right through the implementation pathway to routine patient care and public health.